Creative Touch Permanent Makeup and Aesthetics

Lactic acid is an alpha-hydroxy acid (AHA) naturally present in the skin as a component of the natural moisturising factor (NMF) and produced by keratinocytes during normal metabolism. Applied topically, it exfoliates the stratum corneum through two concurrent pathways: direct calcium chelation that disrupts the desmoglein shielding protecting corneodesmosomes, and pH-mediated activation of Cathepsin D, the enzyme responsible for desmosomal degradation. Uniquely among AHAs, lactic acid also functions as a humectant, contributing to NMF replenishment rather than simply removing surface cells. The L(+) isoform – the biologically active form – demonstrates comparable efficacy to glycolic acid in clinical trials whilst producing fewer irritant responses. This combination makes lactic acid particularly well-suited to barrier-compromised or perimenopausal skin where cell turnover support is needed without inflammatory provocation.

Lactic acid is a 2-hydroxypropanoic acid – an alpha-hydroxy acid (AHA) in which the hydroxyl group sits on the carbon adjacent to the carboxyl group, the structural feature that defines the AHA class. It is one of the few topical exfoliants that is genuinely endogenous to skin: lactic acid is a component of the natural moisturising factor (NMF), the hygroscopic mixture of small molecules produced from filaggrin breakdown that maintains stratum corneum hydration. This endogenous presence is not incidental to its clinical profile – it is the basis for lactic acid’s dual identity as both an exfoliant and a humectant, a combination that is unusual in the AHA class.

The Isoform Distinction

Lactic acid exists as two enantiomers: L(+)-lactic acid and D(-)-lactic acid. The distinction matters for formulation quality and tolerability. A comparative study evaluating multiple AHAs at equimolar concentrations found that L(+)-lactic acid and glycolic acid were the most effective acids for skin hydration and fine line improvement – but that L(+)-lactic acid produced fewer consumer complaints than any other acid tested, including glycolic acid and D(-)-lactic acid. ^[3] D(-)-lactic acid produced irritation at equivalent concentrations, demonstrating that the two forms are not interchangeable despite identical molecular weight. Most well-formulated skincare products specify L-lactic acid or use the L(+) designation; unspecified “lactic acid” on an ingredient label may contain a racemic mixture of both forms.

How It Exfoliates: Two Concurrent Pathways

The exfoliation mechanism of lactic acid – and AHAs generally – is better understood than is often communicated in consumer skincare content. Two pathways operate concurrently:

Calcium chelation and desmoglein disruption: Calcium ions form conjugate structures with desmoglein-1, the transmembrane protein that anchors corneodesmosomes. This calcium binding physically shields desmoglein from enzymatic degradation, maintaining the cell-cell adhesion that holds corneocytes together in the upper stratum corneum. Lactic acid’s chelating activity reduces the free calcium ion concentration available for this shielding interaction, making corneodesmosomes more accessible to degradation and accelerating the natural desquamation process. ^[2]

pH-mediated Cathepsin D activation: The acidic character of lactic acid reduces stratum corneum pH locally. Cathepsin D – a desmosomal protein with an optimal pH of approximately 2.8 – becomes more active as pH falls toward its optimum, increasing the enzymatic breakdown of desmosomal structures independently of the calcium chelation pathway. With repeated use, Cathepsin D expression in the stratum corneum increases progressively, contributing to sustained improvement in cell turnover beyond the immediate acidification effect. ^[2]

The result is accelerated corneocyte shedding that produces the surface texture and tone improvements associated with regular AHA use – without the mechanical disruption of physical exfoliation.

The NMF and Humectant Function

Lactic acid’s presence in NMF places it in a different functional category from glycolic acid, which has no analogous endogenous role. NMF is produced from the proteolytic breakdown of filaggrin during terminal keratinocyte differentiation; its components – including lactic acid, pyrrolidone carboxylic acid, urocanic acid, and amino acids – are hygroscopic molecules that bind water within the stratum corneum and maintain its flexibility and barrier competence.

When applied topically, lactic acid replenishes this component of NMF, directly contributing to stratum corneum hydration through the same mechanism by which endogenously produced lactic acid functions. This is not the same as the film-forming humectancy of glycerin or the water-binding capacity of hyaluronic acid – it is integration into the structural hydration mechanism of the stratum corneum itself. Research has confirmed that lactic acid, alongside niacinamide, promotes ceramide biosynthesis and strengthens the skin barrier, suggesting that the humectant benefit extends to supporting the lipid matrix rather than simply attracting water to the surface. ^[4]

Clinical Pearl A client who reports that lactic acid “doesn’t feel like it’s doing anything” compared to glycolic acid may be experiencing exactly the intended difference: less surface sensation, similar structural benefit. The reduced sting of L(+)-lactic acid on sensitive skin is not evidence of reduced efficacy – it reflects a more tissue-compatible mechanism rather than a weaker one.

Evidence in Mature and Photodamaged Skin

A 22-week double-blind randomised controlled trial at Massachusetts General Hospital evaluated 8% L-lactic acid cream in women aged 40–70 with moderately severe photodamaged skin. L-lactic acid produced statistically significant improvement in overall photodamage severity compared to vehicle (71% achieving at least one grade improvement vs 40% vehicle), with specific improvements in mottled hyperpigmentation, sallowness, and roughness. ^[5] Glycolic acid at equivalent concentration produced comparable overall improvement (76%), confirming that the tolerance advantage of L-lactic acid does not come at the cost of efficacy in this population.

A 14-day controlled study assessing a lactic acid/ceramide combination lotion found statistically significant improvements in both moisturisation and desquamation compared to untreated skin from day 2 onwards, with no adverse events. ^[1] The ceramide combination is mechanistically sensible: lactic acid’s pH reduction supports the ceramide-processing enzyme activity (acidic sphingomyelinase and beta-glucocerebrosidase both have acid pH optima) whilst the ceramide component addresses the structural lipid deficit that AHA use can temporarily exacerbate on already-compromised barrier skin.